Cardiovascular Health Technology Centre Opens at University of Twente, Forging a Path in InnovationMarch 28, 2025
BioVaxys Technology Granted Cease Trade Order Due to Delayed FilingsMarch 4, 2025 BioVaxys Technology Corp. (BIOV) has received a management cease trade order from the British Columbia Securities Commission following delays in its audited annual financial statements. The company expects to complete the filings by March 30, 2025.
